India’s PM Ponders Ways To Encourage Innovative Drug Work
This article was originally published in PharmAsia News
India's prime minister is considering a proposal for the government to support the kind of medical research the pharmaceutical industry finds too expensive and risky to undertake. The proposal is part of a package of regulatory reforms being studied to encourage drug discovery, support clinical trials and provide approvals of products at different stages of development. The package is part of a $2 billion drug research funding plan that emerged from a series of meetings with drug makers to identify roadblocks that stand in the way of innovative drugs. (Click here for more
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.